PhD, Biomedical Sciences, City University of New York
The focus of Dr. Koevary’s current research is the examination of the efficacy of using topically applied drugs to treat diseases of the posterior segment of the eye and central nervous system. Specifically, he is interested in developing a methodology for the delivery of monoclonal antibodies and neurotrophic factors to the retina for the treatment of macular degeneration, retinopathy, and glaucoma. His lab is also involved in a retinoblastoma tumor biology study, specifically to develop new topical therapeutic options for these patients. His current funding is from OneSight, Inc.
Association for Research in Vision and Ophthalmology
American Diabetes Association
20080233053: Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
WO/2009/109900: Stimulation of Ocular Retrobulbar Flow Using Ocular Irritants
IB2009054656: Ophthalmic Administration of a Composition Including Brimonidine as a Mist
Hu, S, Koevary, SB. Pharmacokinetics of topical administration of IgG1 to the optic nerve and retina. ARVO, May, 2013, poster 1077.
Koevary, SB. Selective toxicity of rose bengal to ovarian cancer cells in vitro. Int J Physiol Pathophysiol Pharmacol 2012; 4(2):99-107.
Pardon, LP, Koevary, SB Effects of topical insulin administration on phosphorylated Akt and nitric oxide levels in the rat retina. Journal of Optometry, 2012; 5:196-201.
Skarbez, K, Priestley, Y, Hoepf, M, Koevary, SB Comprehensive review of the effects of diabetes on ocular health. Exp. Review Ophthalmol.. 2010; 5(4):557-577.
Priestley Y, Thiel M, Koevary SB. Systemic and ophthalmic manifestations of West Nile virus infection. Expert Rev. Ophthalmol 2008; 3:279–292.
Koevary, SB, Nussey, J, Kern, TS. Long-term, topical insulin administration increases the severity of retinal vascular pathology in streptozotocin-induced diabetic rats. Optometry 2007; 78:574-581.